Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-11 · accession 0001062993-25-005293 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-11 | IPSC | Cowan Chad | CSO | A - Grant | $0.00 | +19.5K | 230.3K | +9% | $0 |
| D | 2025-03-12 | 2025-03-11 | IPSC | Cowan Chad | CSO | A - Grant | $0.00 | +19.5K | 19.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-11 | A | A | 19,500 | $0.00 | 230,306 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-11 | A | A | 19,500 | $0.00 | 19,500 | D | $0.6 · — to 2035-03-11 | 19,500 Common Stock | (F3) The option vests 25% on March 11, 2026, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through each applicable vesting date. |